Mr Ali Alhamdani is a consultant surgeon working privately at the largest and most advaced hospitals in the UK and world wide: the Wellington Hospital, BUPA Cromwell Hospital and Spire Bushey Hospital and at NHS, at the Whittington NHS Trust.
Mr Alhamdani was awarded his medical degree at the University of Baghdad 1996. He has had extensive training in laparoscopic (keyhole) surgical techniques in the UK, Europe and America and has performed over 2,500 procedures to date. He currently carries out approximately 100 laparoscopic gallbladder procedures per year. He is one of the pioneers in utilizing the new technique STRETTA, minimally invasive endoscopic procedure for the treatment of gastro-oesophageal reflux disease (GORD).
Mr Alhamdani’s training in bariatric, or obesity, surgery conforms with the criteria required by The British Obesity and Metabolic Surgery Society (BOMMS) demonstrated by his fellowship in obesity surgery in Sunderland, UK. He provides the full range of obesity surgery procedures, including gastric bypass, gastric band, sleeve gastrectomy and revisional bariatric surgery. He also performed the new technique of gastric bypass which is the mini gastric bypass with its advantages of less post-operative problems and excellent weight loss results. He performs approximately 100 weight loss procedures per year and has a reputation for performing extremely safe surgery with a very low complication rate and a zero mortality rate.
Mr Alhamdani works with a strong team of allied health professionals to help patients before, during and after surgery. The service provides long term personal follow up which is essential to maintain the excellent results of surgery.
In 2012 Mr Alhamdani set up the first multidisciplinary approach to bariatric patient in Iraq and performed the first gastric bypass and sleeve gastrectomy in the Medical City in Baghdad. He continues to visit countries in the Middle East to help the progression of safe and effective bariatric surgery in that part of the world.
In 2006 Mr Alhamdani completed a Masters research thesis on the molecular changes that occur in the cells within the oesophagus in patients with Barrett’s oesophagus. This pre-cancerous condition arises in patients who have gastro-oesophageal reflux disease (GORD) over a long period of time. Once the epithelial cells in the oesophagus start to show premalignant changes, the risk of progression to adenocarcinoma of the oesophagus is high. Mr Alhamdani set up culture systems to study biopsy samples from patients with Barrett’s oesophagus, demonstrating that bile and acid could be a key factor behind this progression.
Mr Alhamdani current research work involves studying the physical and psychological impact of weight loss surgery. He has subsequently published extensively in the scientific literature and has presented at national and international meetings.
Mr Alhamdani’s priority is the care of his patients. During the consultations, he considers each of his patients to be central to the decision making process for the treatments suggested. Many different factors need to be considered to achieve the best results after surgery and not every procedure is suitable for every patient. Mr Alhamdani sees each patient as an individual with specific and individual needs. The treatment he suggests depends on the patient’s lifestyle, medical history, preferences and medical needs. All of these are taken into consideration before he recommends the available options and the final choice will rest with the patient